BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 16585428)

  • 1. Stimulating: prescribing amidst controversy.
    Martin A
    Am J Psychiatry; 2006 Apr; 163(4):574-7. PubMed ID: 16585428
    [No Abstract]   [Full Text] [Related]  

  • 2. Psychopharmacology: concepts and opinions about the use of stimulant medications.
    Swanson JM; Volkow ND
    J Child Psychol Psychiatry; 2009 Jan; 50(1-2):180-93. PubMed ID: 19220601
    [No Abstract]   [Full Text] [Related]  

  • 3. Bad Medicine: Psychiatric medicine.
    Spence D
    Br J Gen Pract; 2018 Dec; 68(677):583. PubMed ID: 30498152
    [No Abstract]   [Full Text] [Related]  

  • 4. Trends in the prescribing of stimulant medication for the treatment of attention deficit hyperactivity disorder in children and adolescents in New South Wales.
    Salmelainen P
    N S W Public Health Bull; 2002 Jan; 13 Suppl 1():1-65. PubMed ID: 12189396
    [No Abstract]   [Full Text] [Related]  

  • 5. Common Danish standards in prescribing medication for children and adolescents with ADHD.
    Dalsgaard S; Humlum MK; Nielsen HS; Simonsen M
    Eur Child Adolesc Psychiatry; 2014 Sep; 23(9):841-4. PubMed ID: 24374648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correspondence (letter to the editor): Is the treatment the problem?
    Dietrich K
    Dtsch Arztebl Int; 2010 Dec; 107(51-52):918. PubMed ID: 21249139
    [No Abstract]   [Full Text] [Related]  

  • 7. Prescribing for ADHD in primary care.
    Rashid A; Llanwarne N; Lehman R
    Br J Gen Pract; 2018 Apr; 68(669):170-171. PubMed ID: 29592923
    [No Abstract]   [Full Text] [Related]  

  • 8. The use of medication against attention deficit/hyperactivity disorder in Denmark: a drug use study from a patient perspective.
    Pottegård A; Bjerregaard BK; Glintborg D; Kortegaard LS; Hallas J; Moreno SI
    Eur J Clin Pharmacol; 2013 Mar; 69(3):589-98. PubMed ID: 22811260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychotropic drug use in very young children.
    Coyle JT
    JAMA; 2000 Feb; 283(8):1059-60. PubMed ID: 10697069
    [No Abstract]   [Full Text] [Related]  

  • 10. Alternative national guidelines for treating attention and depression problems in children: comparison of treatment approaches and prescribing rates in the United Kingdom and United States.
    Murphy JM; McCarthy AE; Baer L; Zima BT; Jellinek MS
    Harv Rev Psychiatry; 2014; 22(3):179-92. PubMed ID: 24736521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correspondence (letter to the editor): What about the dam break upstream?
    Börner J
    Dtsch Arztebl Int; 2010 Dec; 107(51-52):918-9. PubMed ID: 21249140
    [No Abstract]   [Full Text] [Related]  

  • 12. Correspondence (letter to the editor): Uncritical prescription.
    Neraal T
    Dtsch Arztebl Int; 2010 Dec; 107(51-52):919; author reply 919-20. PubMed ID: 21249142
    [No Abstract]   [Full Text] [Related]  

  • 13. Use of growth hormone for non-growth hormone deficient children.
    Diller L
    JAMA; 1996 Dec; 276(23):1877-8; author reply 1878. PubMed ID: 8968011
    [No Abstract]   [Full Text] [Related]  

  • 14. Stimulants in AD/HD, a controversial treatment only in Sweden?
    Ekman JT; Gustafsson PA
    Eur Child Adolesc Psychiatry; 2000 Dec; 9(4):312-3. PubMed ID: 11202108
    [No Abstract]   [Full Text] [Related]  

  • 15. Psychostimulant prescriptions by psychiatrists higher than expected: a self-report survey.
    Beck C; Silverstone P; Glor K; Dunn J
    Can J Psychiatry; 1999 Sep; 44(7):680-4. PubMed ID: 10500869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are stimulants overprescribed for youths with ADHD?
    Safer DJ
    Ann Clin Psychiatry; 2000 Mar; 12(1):55-62. PubMed ID: 10798827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are stimulants overprescribed?
    Perry R; Gilbert EM; Angkustsiri K
    J Am Acad Child Adolesc Psychiatry; 2000 Mar; 39(3):269-70; author reply 270-1. PubMed ID: 10714041
    [No Abstract]   [Full Text] [Related]  

  • 18. Prevalence, incidence and persistence of ADHD drug use in Japan.
    Okumura Y; Usami M; Okada T; Saito T; Negoro H; Tsujii N; Fujita J; Iida J
    Epidemiol Psychiatr Sci; 2019 Dec; 28(6):692-696. PubMed ID: 29804548
    [No Abstract]   [Full Text] [Related]  

  • 19. Are stimulants overprescribed?
    Diller LH
    J Am Acad Child Adolesc Psychiatry; 2000 Mar; 39(3):269; author reply 270-1. PubMed ID: 10714040
    [No Abstract]   [Full Text] [Related]  

  • 20. The difference between efficacy and effectiveness research in studying attention-deficit/hyperactivity disorder.
    Wolraich ML
    Arch Pediatr Adolesc Med; 1999 Dec; 153(12):1220-1. PubMed ID: 10591296
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.